119 related articles for article (PubMed ID: 7733364)
1. Effects of Hoe-140 and ramiprilat on arteriolar tone and dilation to bradykinin in skeletal muscle of rats.
Koller A; Rodenburg JM; Kaley G
Am J Physiol; 1995 Apr; 268(4 Pt 2):H1628-33. PubMed ID: 7733364
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
Oliveira MA; Fortes ZB; Santos RA; Kosla MC; De Carvalho MH
Peptides; 1999; 20(10):1195-201. PubMed ID: 10573291
[TBL] [Abstract][Full Text] [Related]
3. Endothelial impairment inhibits prostaglandin and EDRF-mediated arteriolar dilation in vivo.
Koller A; Messina EJ; Wolin MS; Kaley G
Am J Physiol; 1989 Dec; 257(6 Pt 2):H1966-70. PubMed ID: 2513732
[TBL] [Abstract][Full Text] [Related]
4. L-arginine analogues blunt prostaglandin-related dilation of arterioles.
Koller A; Sun D; Messina EJ; Kaley G
Am J Physiol; 1993 Apr; 264(4 Pt 2):H1194-9. PubMed ID: 8476097
[TBL] [Abstract][Full Text] [Related]
5. Comparable effects of arteriolar and capillary stimuli on blood flow in rat skeletal muscle.
Mitchell D; Yu J; Tyml K
Microvasc Res; 1997 Jan; 53(1):22-32. PubMed ID: 9056473
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
Fernandes L; Fortes ZB; Nigro D; Tostes RC; Santos RA; Catelli De Carvalho MH
Hypertension; 2001 Feb; 37(2 Pt 2):703-9. PubMed ID: 11230360
[TBL] [Abstract][Full Text] [Related]
8. Calcium-activated potassium channel-mediated arteriolar relaxation during endotoxic shock.
Price JM; Baker CH; Bond RF
Shock; 1997 Apr; 7(4):294-9. PubMed ID: 9110416
[TBL] [Abstract][Full Text] [Related]
9. Modified arteriolar responses to ATP after impairment of endothelium by light-dye techniques in vivo.
Koller A; Rodenburg JM; Wolin MS; Messina EJ; Kaley G
Microvasc Res; 1991 Jan; 41(1):63-72. PubMed ID: 1904977
[TBL] [Abstract][Full Text] [Related]
10. Regulation of arteriolar tone and responses via L-arginine pathway in skeletal muscle.
Kaley G; Koller A; Rodenburg JM; Messina EJ; Wolin MS
Am J Physiol; 1992 Apr; 262(4 Pt 2):H987-92. PubMed ID: 1566917
[TBL] [Abstract][Full Text] [Related]
11. Short-term angiotensin converting enzyme inhibition reduces basal tone and dilator reactivity in skeletal muscle arterioles.
Frisbee JC; Lombard JH
Am J Hypertens; 2000 Apr; 13(4 Pt 1):389-95. PubMed ID: 10821341
[TBL] [Abstract][Full Text] [Related]
12. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the vascular response to kinins by inhibition of myocardial kininases.
Dendorfer A; Wolfrum S; Schäfer U; Stewart JM; Inamura N; Dominiak P
Hypertension; 2000 Jan; 35(1 Pt 1):32-7. PubMed ID: 10642271
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
Ekelund U
Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibitors of prostaglandin synthesis in skeletal muscle of the rat.
Messina EJ; Weiner R; Kaley G
Circ Res; 1975 Oct; 37(4):430-7. PubMed ID: 1182934
[TBL] [Abstract][Full Text] [Related]
16. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
Hartman JC; Wall TM; Hullinger TG; Shebuski RJ
J Cardiovasc Pharmacol; 1993 Jun; 21(6):996-1003. PubMed ID: 7687728
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-associated vasodilators in rat skeletal muscle microcirculation.
Kaley G; Rodenburg JM; Messina EJ; Wolin MS
Am J Physiol; 1989 Mar; 256(3 Pt 2):H720-5. PubMed ID: 2493747
[TBL] [Abstract][Full Text] [Related]
18. Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.
Wall TM; Linseman DA; Hartman JC
Eur J Pharmacol; 1996 Jun; 306(1-3):165-74. PubMed ID: 8813629
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
[TBL] [Abstract][Full Text] [Related]
20. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
